Lee Danner & Bass Inc Pfizer Inc Transaction History

Lee Danner & Bass Inc

$1.42 Billion
Q3 2024

A detailed history of Lee Danner & Bass Inc transactions in Pfizer Inc stock. As of the latest transaction made, Lee Danner & Bass Inc holds 126,241 shares of PFE stock, worth $3.33 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

126,241

Previous 128,861 2.03%

Holding current value

$3.33 Million

Previous $3.61 Million 1.3%

% of portfolio

0.26%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$27.7 - $31.39 $72,574 - $82,241	-2,620 Reduced 2.03%	126,241 $3.65 Million
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $196,623 - $230,406	-7,784 Reduced 5.7%	128,861 $3.61 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $528,348 - $686,266	-20,220 Reduced 12.89%	136,645 $3.93 Million
Q3 2023 Oct 27, 2023	SELL	$32.09 - $37.51 $15,692 - $18,342	-489 Reduced 0.31%	156,865 $5.2 Million
Q2 2023 Jul 31, 2023	SELL	$36.12 - $41.79 $137,617 - $159,219	-3,810 Reduced 2.36%	157,354 $5.77 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $604,557 - $787,045	-15,348 Reduced 8.7%	161,164 $6.58 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $430,776 - $562,331	-10,318 Reduced 5.52%	176,512 $9.04 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $102,398 - $125,002	-2,340 Reduced 1.24%	186,830 $8.18 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $231,486 - $274,470	-4,975 Reduced 2.56%	189,170 $9.92 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $81,160 - $100,568	1,774 Added 0.92%	194,145 $10.1 Million
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $84,995 - $125,991	-2,057 Reduced 1.06%	192,371 $11.4 Million
Q3 2021 Nov 01, 2021	BUY	$39.25 - $50.42 $46,393 - $59,596	1,182 Added 0.61%	194,428 $8.36 Million
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $223,396 - $253,070	6,221 Added 3.33%	193,246 $7.57 Million
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $55,291 - $62,358	1,651 Added 0.89%	187,025 $6.78 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $750,330 - $954,110	22,418 Added 13.76%	185,374 $6.82 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $91,376 - $107,205	-2,878 Reduced 1.74%	162,956 $5.98 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $176,774 - $214,453	-5,869 Reduced 3.42%	165,834 $5.42 Million
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $279,003 - $398,635	10,322 Added 6.4%	171,703 $5.6 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $121,771 - $138,194	3,699 Added 2.35%	161,381 $6.32 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $76,156 - $98,752	2,344 Added 1.51%	157,682 $5.67 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $297,541 - $334,069	-8,046 Reduced 4.92%	155,338 $6.73 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $90,862 - $99,827	-2,423 Reduced 1.46%	163,384 $6.94 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $12,579 - $14,342	-327 Reduced 0.2%	165,807 $7.24 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $148,841 - $180,535	-4,318 Reduced 2.53%	166,134 $7.32 Million
Q2 2018 Nov 02, 2018	BUY	$32.98 - $35.16 $64,179 - $68,421	1,946 Added 1.15%	170,452 $6.18 Million
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $42,115 - $44,899	-1,277 Reduced 0.75%	168,506 $6.73 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $133,990 - $155,446	4,199 Added 2.54%	169,783 $6.03 Million
Q4 2017 Feb 02, 2018	SELL	$33.26 - $35.29 $212,464 - $225,432	-6,388 Reduced 3.71%	165,584 $6 Million
Q3 2017 Oct 27, 2017	BUY	$31.0 - $34.15 $5.33 Million - $5.87 Million	171,972	171,972 $6.14 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Account

Lee Danner & Bass Inc Pfizer Inc Transaction History